Serum ischemia-modified albumin levels in adolescent smokers

Basit Öğe Kaydı
dc.contributor.authorBattal, Fatih
dc.contributor.authorTekin, Mustafa
dc.contributor.authorAylanç, Hakan
dc.contributor.authorYlldlrlm, Şule
dc.contributor.authorTürkön, Hakan
dc.contributor.authorBinneto?lu, Fatih Köksal
dc.contributor.authorKaymaz, Nazan
dc.date.accessioned2025-01-27T18:56:22Z
dc.date.available2025-01-27T18:56:22Z
dc.date.issued2018
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractIt is known that the biochemical marker linked to tissue ischemia, ischemia-modified albumin (IMA), is related to oxidative stress. Cigarette smoking is a situation with increased oxidative stress causing cell damage and it is thought that many of the negative effects linked to smoking may occur after the biological material in the body is exposed to oxidative damage. This study aimed to identify variability in serum IMA levels in adolescents who smoke. This case-control study comprised 60 adolescents without any chronic disease. The smoking group was 30 adolescents between the ages of 14 and 17 years who smoked, while the control group was 30 healthy adolescents who did not smoke. Blood samples were collected from all subjects and serum IMA levels and serum nicotine metabolites were determined. The serum IMA levels in the adolescents who smoked were 0.452±0.094 absorbance unit (ABSU), while the control group had ASBU levels of 0.427±0.054. There was no significant difference between the groups in terms of serum IMA levels (p=0.210). There was a significant difference between the control and smoking groups in terms of serum nicotine metabolite levels (p<0.001). Among adolescents who smoke, serum IMA levels may not be a good marker for oxidative stress. © 2018 Walter de Gruyter GmbH, Berlin/Boston.
dc.identifier.doi10.1515/ijamh-2015-0128
dc.identifier.issn0334-0139
dc.identifier.issue1
dc.identifier.scopus2-s2.0-85043514176
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1515/ijamh-2015-0128
dc.identifier.urihttps://hdl.handle.net/20.500.12428/12960
dc.identifier.volume30
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWalter de Gruyter GmbH
dc.relation.ispartofInternational Journal of Adolescent Medicine and Health
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20250125
dc.subjectadolescents; ischemia-modified albumin; smoking
dc.titleSerum ischemia-modified albumin levels in adolescent smokers
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu